AAP
TYRA icon

Arax Advisory Partners’s Tyra Biosciences TYRA Stock Holding History

Arax Advisory Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.78K Buy
+87
New +$2.88K ﹤0.01% 4740
2026
Q1 		– Sell
-3
Closed -$79 – 4335
2025
Q4 		$79 Sell
3
-82
-96% -$1.51K ﹤0.01% 3863
2025
Q3 		$1.19K Buy
+85
New +$969 ﹤0.01% 3220
2024
Q4 		– Sell
-7
Closed -$165 – 2749
2024
Q3 		$165 Hold
7
– – ﹤0.01% 2527
2024
Q2 		$112 Buy
+7
New +$120 ﹤0.01% 2484

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Arax Advisory Partners's TYRA Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Tyra Biosciences (TYRA) in Q2 2026: 87 shares worth $2.78K. The stake represents ﹤0.01% of the portfolio and ranks #4740 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in TYRA as recently as Q4 2025.

Arax Advisory Partners first reported a position in TYRA in Q2 2024 and has held it in 5 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Arax Advisory Partners held 87 shares of Tyra Biosciences worth $2.78K as of Q2 2026.
  • Tyra Biosciences was a new Arax Advisory Partners position in Q2 2026.
  • Tyra Biosciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4740 holding.
  • Arax Advisory Partners first reported a position in Tyra Biosciences in Q2 2024 and has held it in 5 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.